(March 17, 2020 / JNS) An Israeli startup will donate around 120,000 masks made with an anti-pathogen, anti-bacterial fabric it developed that could help stop the spread of coronavirus (COVID-19), to Israeli hospitals, medical professionals and coronavirus patients, reported The Jerusalem Post.
“Sonovia Ltd. is determined to use its novel technology for the good of the State of Israel,” the company said in a release. “In this crucial period, it is hoped that our efforts will help curtail the number of clinical cases of coronavirus we see in Israel in the upcoming weeks and months.”
Sonovia developed an almost-permanent, ultrasonic, fabric-finishing technology that “mechanically infuses metal oxides nanoparticles onto textiles during an ultrasonic-assisted impregnation process with the specialized chemical compound turning the textiles into highly effective blocks against bacteria and fungi,” the website NoCamels reported.
It was based on a process created at Bar-Ilan University in Ramat Gan.
Dr. Jason Migdal, a research scientist with Sonovia, said any airborne bacteria will be destroyed upon contact with the surface of the mask. He explained that coronavirus is spread via aerosol and direct contact, making any antiviral personal protective equipment “of crucial importance to combat the transmission of this viral epidemic.”
On Sunday, the company imported all its stored fabric from its R&D line in Germany to its headquarters in Israel and then to a factory in Jerusalem that will make the masks, according to The Jerusalem Post. Migdal said the masks will be ready by next week.
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.